Italia markets closed

Merck & Co., Inc. (MRKCL.SN)

Santiago - Santiago Prezzo differito. Valuta in CLP.
Aggiungi a watchlist
129.520,00+10.420,00 (+8,75%)
In data: 10:50AM CLST. Mercato aperto.
Schermo intero
Chiusura precedente119.100,00
Aperto130.550,00
Denaro0,00 x N/D
Lettera129.520,00 x N/D
Min-Max giorno129.520,00 - 130.550,00
Intervallo di 52 settimane77.794,00 - 130.550,00
Volume10
Media Volume28
CapitalizzazioneN/D
Beta (5 anni mensile)0,38
Rapporto PE (ttm)23.182,39
EPS (ttm)5,59
Prossima data utili25 apr 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.

    PRA023 is a novel, late-stage candidate for ulcerative colitis and Crohn’s disease and other autoimmune conditions Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology RAHWAY, N.J. and SAN DIEGO, April 16, 2023 (GLOBE NEWSWIRE) -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Prometheus Biosciences, Inc. (“Prometheus”) (Nasdaq: RXDX) today announced that the companies have entered into a